MCID: TNG002
MIFTS: 61

Tangier Disease malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Eye diseases, Metabolic diseases, Endocrine diseases

Aliases & Classifications for Tangier Disease

About this section
Sources:
11Disease Ontology, 12diseasecard, 13DISEASES, 24GeneTests, 25Genetics Home Reference, 26GTR, 29ICD10, 30ICD10 via Orphanet, 36MedGen, 38MeSH, 39MESH via Orphanet, 44NCIt, 47NIH Rare Diseases, 49Novoseek, 51OMIM, 53Orphanet, 61SNOMED-CT, 63The Human Phenotype Ontology, 67UMLS, 68UMLS via Orphanet, 69UniProtKB/Swiss-Prot
See all MalaCards sources

Aliases & Descriptions for Tangier Disease:

Name: Tangier Disease 51 11 47 24 25 53 69 26 12 49 38 13 67
Analphalipoproteinemia 25 53 69
Familial High Density Lipoprotein Deficiency Disease 47 25
Alpha High Density Lipoprotein Deficiency Disease 47 25
Familial High Density Lipoprotein Deficiency 11 24
Hypoalphalipoproteinemia, Familial 24 67
Hdl Lipoprotein Deficiency Disease 47 25
Familial Hypoalphalipoproteinemia 11 25
a-Alphalipoprotein Neuropathy 47 25
Cholesterol Thesaurismosis 47 25
Tangier Disease Neuropathy 25 67
Familial Hdl Deficiency 24 67
Defective Adenosine Triphosphate-Binding Cassette Transporter A1 53
 
High Density Lipoprotein Deficiency, Tangier Type 47
Atp-Binding Cassette Transporter A1 Deficiency 53
Lipoprotein Deficiency Disease, Hdl, Familial 25
High Density Lipoprotein Deficiency, Type 1 47
Familial Alpha-Lipoprotein Deficiency 11
High Density Lipoprotein Deficiency 1 69
Familial Hypoalphalipo-Proteinemia 47
Tangier Hereditary Neuropathy 25
Analphalipo-Proteinemia 47
Hdldt1 47
Hdld1 69
Tgd 69

Characteristics:

Orphanet epidemiological data:

53
tangier disease:
Inheritance: Autosomal recessive; Prevalence: <1/1000000 (Worldwide),<1/1000000 (Europe); Age of onset: Childhood,Infancy,Neonatal; Age of death: normal life expectancy

HPO:

63
tangier disease:
Inheritance: autosomal recessive inheritance

Classifications:



External Ids:

OMIM51 205400
Disease Ontology11 DOID:1388
ICD1029 E78.6
MeSH38 D013631
NCIt44 C85182
SNOMED-CT61 15346004, 190783007
Orphanet53 ORPHA31150
ICD10 via Orphanet30 E78.6
MESH via Orphanet39 D013631
UMLS via Orphanet68 C0039292
MedGen36 C0039292

Summaries for Tangier Disease

About this section
Genetics Home Reference:25 Tangier disease is an inherited disorder characterized by significantly reduced levels of high-density lipoprotein (HDL) in the blood. HDL transports cholesterol and certain fats called phospholipids from the body's tissues to the liver, where they are removed from the blood. HDL is often referred to as "good cholesterol" because high levels of this substance reduce the chances of developing heart and blood vessel (cardiovascular) disease. Because people with Tangier disease have very low levels of HDL, they have a moderately increased risk of cardiovascular disease.

MalaCards based summary: Tangier Disease, also known as analphalipoproteinemia, is related to polyneuropathy and peripheral artery disease, and has symptoms including visual impairment, ectropion and dry skin. An important gene associated with Tangier Disease is ABCA1 (ATP Binding Cassette Subfamily A Member 1), and among its related pathways are Nuclear receptors in lipid metabolism and toxicity and Vitamin digestion and absorption. Affiliated tissues include liver, heart and tonsil, and related mouse phenotypes are liver/biliary system and vision/eye.

NIH Rare Diseases:47 Tangier disease is an inherited disorder characterized by significantly reduced levels of high-density lipoprotein (HDL) - the 'good cholesterol' - in the blood. Because people with Tangier disease have very low levels of HDL, they have a moderately increased risk of cardiovascular disease. Tangier disease is caused by mutations in the ABCA1 gene. It is inherited in an autosomal recessive pattern. Last updated: 8/19/2011

OMIM:51 Tangier disease is an autosomal recessive disorder characterized by markedly reduced levels of plasma high density... (205400) more...

UniProtKB/Swiss-Prot:69 High density lipoprotein deficiency 1: Recessive disorder characterized by absence of high density lipoprotein (HDL) cholesterol from plasma, accumulation of cholesteryl esters, premature coronary artery disease (CAD), hepatosplenomegaly, recurrent peripheral neuropathy and progressive muscle wasting and weakness.

Wikipedia:70 Tangier disease (also known as Familial alpha-lipoprotein deficiency) or Hypoalphalipoproteinemia is a... more...

Related Diseases for Tangier Disease

About this section

Diseases related to Tangier Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 82)
idRelated DiseaseScoreTop Affiliating Genes
1polyneuropathy27.9ABCA1, APOA1, APOA2, APOB, APOE, LCAT
2peripheral artery disease26.8ABCA1, ALB, APOA1, APOA2, APOB, APOE
3abca1-associated familial high density lipoprotein deficiency12.3
4abca1-related familial high density lipoprotein deficiency12.3
5apoa1-associated familial high density lipoprotein deficiency12.3
6hypoalphalipoproteinemia11.2
7hypertriglyceridemia11.2
8intellectual disability-developmental delay-contractures syndrome10.5APOA1, LCAT
9amyoplasia mandibulofacial dysostosis10.5APOA1, APOA2
10lipoprotein glomerulopathy10.4APOE, LCAT
11amelogenesis imperfecta, type iia310.4APOA1, APOE
12respiratory syncytial virus infectious disease10.3APOE, LPA
13tyrosinemia, type ii10.3APOA1, APOA2, LCAT
14dyserythropoietic anemia, congenital, type ii10.2APOA1, LCAT, LPA
15arthritis10.2ABCA1, APOE, LPA
16afibrinogenemia, congenital10.2APOA1, APOA2, LPA
17neuropathy10.1
18alveolar periostitis10.1ALB, LCAT
19syringomyelia10.0
20atrial septal defect 910.0ABCA1, NPC1
21dysmorphism-pectus carinatum-joint laxity syndrome10.0APOB, APOE
22catel-manzke syndrome10.0
23atherosclerosis10.0
24hypercholesterolemia, due to ligand-defective apo b10.0APOB, APOE
25shwachman-diamond type metaphyseal dysplasia10.0APOA1, APOB
26casr-related disorders9.9APOB, APOE
27heart disease9.9
28legg-calve-perthes disease9.9APOA1, APOB
29fetal methyl mercury syndrome9.8APOA1, APOB, LCAT
30blue toe syndrome9.8APOB, LCAT
31leprosy9.8
32fish-eye disease9.8
33eye disease9.8
34degos 'en cocarde' erythrokeratoderma9.8APOB, APOE, LCAT
35hypobetalipoproteinemia9.8APOB, APOE, LCAT
36peripheral degeneration of cornea9.8APOB, APOE
37dermal unilateral segmental cavernous angioma9.7APOB, APOE, LPA
38conjunctival disease9.7ALB, APOA1, APOE, CETP
39malaria9.7
40werner syndrome9.7
41artery disease9.7
42tonsillitis9.7
43pancreatitis9.7
44neuronitis9.7
45amyloid neuropathy9.7
46apo a-i deficiency9.7
47lewis-sumner syndrome9.7
48posterior foramen magnum meningioma9.7APOA1, APOB, NPC1
49bone angioendothelial sarcoma9.6APOB, LPA
50islet cell tumor9.6ABCA1, APOA1, APOB, APOE

Graphical network of the top 20 diseases related to Tangier Disease:



Diseases related to tangier disease

Symptoms for Tangier Disease

About this section

Symptoms by clinical synopsis from OMIM:

205400

Clinical features from OMIM:

205400

Human phenotypes related to Tangier Disease:

 63 (show all 18)
id Description HPO Frequency HPO Source Accession
1 visual impairment63 HP:0000505
2 ectropion63 HP:0000656
3 dry skin63 HP:0000958
4 hyporeflexia63 HP:0001265
5 facial diplegia63 HP:0001349
6 myocardial infarction63 HP:0001658
7 left ventricular hypertrophy63 HP:0001712
8 splenomegaly63 HP:0001744
9 nail dysplasia63 HP:0002164
10 hepatomegaly63 HP:0002240
11 hypoalphalipoproteinemia63 HP:0003233
12 peripheral axonal neuropathy63 HP:0003477
13 distal amyotrophy63 HP:0003693
14 impaired pain sensation63 HP:0007328
15 opacification of the corneal stroma63 HP:0007759
16 nail dystrophy63 HP:0008404
17 impaired temperature sensation63 HP:0010829
18 peripheral demyelination63 HP:0011096

UMLS symptoms related to Tangier Disease:


hepatomegaly, dry skin

Drugs & Therapeutics for Tangier Disease

About this section

Drugs for Tangier Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
GlyburideapprovedPhase 411110238-21-83488
Synonyms:
1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea
1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea
1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea
1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea
10238-21-8
5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide
5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide
5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide
AB00051949
AC1L1G1Q
AC1Q44V7
AKOS001487495
Abbenclamide
Adiab
Apo-Glibenclamide
Azuglucon
BIDD:GT0239
BPBio1_000344
BRD-K36927236-001-06-0
BRN 2230085
BSPBio_000312
BSPBio_001351
BSPBio_003053
Bastiverit
Benclamin
Betanase
Betanese 5
Bio-0156
Bio1_000076
Bio1_000565
Bio1_001054
Bio2_000071
Bio2_000551
C07022
C23H28ClN3O5S
CAS-10238-21-8
CBiol_001790
CHEBI:5441
CHEMBL472
CID3488
CPD000058229
Calabren
Cytagon
D00336
D005905
DB01016
Daonil
Debtan
Dia-basan
Diabeta
Diabeta (TN)
Diabiphage
Dibelet
DivK1c_000481
Duraglucon
EINECS 233-570-6
EU-0100499
Euclamin
Euglucan
Euglucon
Euglucon 5
Euglucon N
Euglykon
G 0639
G0639_SIAL
G0639_SIGMA
G2539_SIAL
GBN 5
Gen-Glybe
Gewaglucon
Gilemal
Glamide
Glibadone
Gliban
Gliben
Gliben-Puren N
Glibenbeta
Glibenclamid AL
Glibenclamid Basics
Glibenclamid Fabra
Glibenclamid Genericon
Glibenclamid Heumann
Glibenclamid Riker M
Glibenclamid Riker M.
Glibenclamid-Cophar
Glibenclamid-Ratiopharm
Glibenclamida
Glibenclamida [INN-Spanish]
Glibenclamide
Glibenclamide (JP15/INN)
Glibenclamidum
Glibenclamidum [INN-Latin]
Glibenil
Glibens
Glibesyn
Glibet
Glibetic
Glibil
Gliboral
Glicem
Glidiabet
Glimel
Glimide
Glimidstata
Glisulin
Glitisol
Glubate
Gluben
Gluco-Tablimen
Glucobene
Glucohexal
Glucolon
Glucomid
Glucoremed
Glucoven
Glyben
Glybenclamide
Glybenzcyclamide
Glyburide
Glyburide (USP)
Glyburide (micronized)
Glyburide [USAN]
 
Glycolande
Glycomin
Glynase
Glynase (TN)
HB 419
HB 420
HB-419
HB-420
HB419
HB420
HMS1361D13
HMS1568P14
HMS1791D13
HMS1922L08
HMS1989D13
HMS2089L06
HMS2093P04
HMS501I03
Hemi-Daonil
Hexaglucon
Humedia
I06-0716
IDI1_000481
IDI1_033821
KBio1_000481
KBio2_000071
KBio2_000730
KBio2_002639
KBio2_003298
KBio2_005207
KBio2_005866
KBio3_000141
KBio3_000142
KBio3_002273
KBioGR_000071
KBioGR_001897
KBioSS_000071
KBioSS_000730
LS-159295
Lederglib
Libanil
Lisaglucon
Lopac-G-0639
Lopac0_000499
MLS000069721
MLS001077262
Malix
Maninil
Med-Glionil
Melix
Micronase
Micronase (TN)
Micronized glyburide
Miglucan
MolPort-000-784-850
N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea
N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N -cyclohexylurea
N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea
NCGC00015467-01
NCGC00015467-02
NCGC00015467-06
NCGC00015467-16
NCGC00016689-01
NCGC00023447-02
NCGC00023447-04
NCGC00023447-05
NCGC00023447-06
NCGC00023447-07
NCGC00023447-08
NCGC00023447-09
NCGC00023447-10
NCGC00023447-11
NCGC00023447-12
NINDS_000481
Nadib
Neogluconin
Norglicem 5
Normoglucon
Novo-Glyburide
Oprea1_764617
Orabetic
Pira
Praeciglucon
PresTab
Prestwick0_000316
Prestwick1_000316
Prestwick2_000316
Prestwick3_000316
Prestwick_569
Probes1_000431
Probes2_000378
Prodiabet
Renabetic
S1716_Selleck
SAM002564212
SMR000058229
SPBio_001831
SPBio_002531
SPECTRUM2300229
SR-01000000196-5
STK362992
Semi-Daonil
Semi-Euglucon
Semi-Gliben-Puren N
Semi-daonil
Spectrum2_001816
Spectrum3_001327
Spectrum4_001199
Spectrum5_001631
Spectrum_000250
Sugril
Suraben
Tiabet
Tocris-0911
U 26452
U-26452
UNII-SX6K58TVWC
UPCMLD-DP006
UPCMLD-DP006:001
UR 606
Yuglucon
ZINC00537805
glibenclamide
glyburide
2Hypoglycemic AgentsPhase 45733
3
Adenosineapproved, investigational39758-61-760961
Synonyms:
(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-D-Ribofuranose
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-delta-Ribofuranose
1odi
2fqy
2gl0
30143-02-3
4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside
46946-45-6
46969-16-8
58-61-7
6-Amino-9-.beta.-ribofuranosyl-9H-purine
6-Amino-9-beta-D-ribofuranosyl-9H-purine
6-Amino-9beta-D-ribofuranosyl-9H-purine
6-Amino-9beta-delta-ribofuranosyl-9H-purine
9-(beta-D-Arabinofuranosyl)adenine
9-beta-D-Arabinofuranosyladenine
9-beta-D-Ribofuranosidoadenine
9-beta-D-Ribofuranosyl-9H-purin-6-amine
9-beta-D-Ribofuranosyladenine
9-beta-delta-Arabinofuranosyladenine
9-beta-delta-Ribofuranosidoadenine
9-beta-delta-Ribofuranosyl-9H-purin-6-amine
9-beta-delta-Ribofuranosyladenine
9beta-D-Ribofuranosyladenine
9beta-D-ribofuranosyl-9H-Purin-6-amine
9beta-delta-Ribofuranosyladenine
9beta-delta-ribofuranosyl-9H-Purin-6-amine
A0152
A4036_SIGMA
A9251_SIGMA
AC1L1U8O
AC1Q1ID3
AC1Q52XU
ADN
AI3-52413
Ade-Rib
Ade-rib
Adenin riboside
Adenine 9-beta-D-arabinofuranoside
Adenine deoxyribonucleoside
Adenine nucleoside
Adenine riboside
Adenine-9-beta-D-ribofuranoside
Adenine-9beta-D-Ribofuranoside
Adenine-9beta-delta-Ribofuranoside
Adenocard
Adenocard (TN)
Adenocard, Adenosine
Adenocor
Adenoscan
Adenoscan (TN)
Adenosin
Adenosin [German]
Adenosina
Adenosine (JAN/USP)
Adenosine [USAN:BAN]
Adenosine, homopolymer
Adenosinum
Adensoine
Adenyldeoxyriboside
Ado
Adénosine
BB_NC-0565
BSPBio_001796
Bio1_000437
 
Bio1_000926
Bio1_001415
Boniton
C00212
CCRIS 2557
CHEBI:16335
CHEMBL477
CID60961
Caswell No. 010B
D000241
D00045
DB00640
Deoxyadenosine
Desoxyadenosine
EA6C60C2-6AFB-4264-A2F0-541373DB950E
EINECS 200-389-9
FT-0082881
HMS1920A13
HMS2091G13
KBio3_001296
LS-15085
MEDR-640
MLS000069638
MLS002153227
MolPort-001-838-229
Myocol
NCGC00023673-03
NCGC00023673-04
NCGC00023673-05
NCGC00023673-06
NCGC00023673-07
NSC 627048
NSC 7652
NSC627048
NSC7652
Nucleocardyl
Pallacor
Polyadenosine
Polyriboadenosine
S1647_Selleck
SDCCGMLS-0003108.P003
SMR000058216
SPBio_001194
SPECTRUM1500107
SR 96225
SR-96225
SUN-Y4001
Sandesin
Spectrum2_001257
Spectrum3_000288
TL8003749
UNII-K72T3FS567
USAF CB-10
V0098
Vidarabine
ZINC02169830
adenine-D-ribose
adenosine
b-D-Adenosine
beta-Adenosine
beta-D-Adenosine
beta-D-Ribofuranoside, adenine-9
beta-delta-Adenosine
bmse000061
nchembio.143-comp9
nchembio.186-comp109
nchembio.2007.56-comp13
nchembio.64-comp4
nchembio706-5
4Pharmaceutical Solutions7793

Interventional clinical trials:

idNameStatusNCT IDPhase
1R230C and C230C Variants of ABCA1 and Glyburide ResponseCompletedNCT01456650Phase 4
2Effect of High Protein Diet on Cardiovascular Diseases Risk Factors Among Overweight and Obese ChildrenCompletedNCT01886482Phase 3
3Effect of High Protein Diet on Adiponectin and Inflammation Among Overweight and Obese ChildrenCompletedNCT01886495Phase 3
4High Protein Weight Loss Diet, High Sensitivity C-Reactive Protein and Cardiovascular Risks Among Obese WomenCompletedNCT01763528Phase 3
5Quantitative Genetic Analysis of Lipid Research Clinic Family DataCompletedNCT00005188
6Mendelian Reverse Cholesterol Transport StudyActive, not recruitingNCT01782027

Search NIH Clinical Center for Tangier Disease


Cochrane evidence based reviews: tangier disease

Genetic Tests for Tangier Disease

About this section

Genetic tests related to Tangier Disease:

id Genetic test Affiliating Genes
1 Tangier Disease26 24 ABCA1
2 Familial High Density Lipoprotein Deficiency24 APOA1

Anatomical Context for Tangier Disease

About this section

MalaCards organs/tissues related to Tangier Disease:

35
Liver, Heart, Tonsil, Lymph node, Spleen, Skin, Eye

Animal Models for Tangier Disease or affiliated genes

About this section

MGI Mouse Phenotypes related to Tangier Disease:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053708.3ABCA1, ABCG1, ALB, APOA1, APOB, APOE
2MP:00053918.1ABCA1, APOB, APOE, LCAT, NPC1, PLTP
3MP:00053767.4ABCA1, ABCG1, ALB, APOA1, APOA2, APOB

Publications for Tangier Disease

About this section

Articles related to Tangier Disease:

(show top 50)    (show all 195)
idTitleAuthorsYear
1
Tangier disease in a Turkish family. (25335997)
2014
2
Tangier disease: epidemiology, pathophysiology, and management. (22913675)
2012
3
Wild type and Tangier disease ABCA1 mutants modulate cellular amyloid-I^ production independent of cholesterol efflux activity. (21860089)
2011
4
Tangier disease phenotype diversity in dizygous twin sisters. (20070997)
2010
5
Impaired insulin secretion in four Tangier disease patients with ABCA1 mutations. (19556721)
2009
6
Images in cardiovascular medicine. Tangier disease in severely progressive coronary and peripheral artery disease. (19470903)
2009
7
Severe Tangier disease with a novel ABCA1 gene mutation. (18955690)
2008
8
The establishment of telomerase-immortalized Tangier disease cell lines indicates the existence of an apolipoprotein A-I-inducible but ABCA1-independent cholesterol efflux pathway. (15001567)
2004
9
Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts. (11181755)
2001
10
Novel approaches to treating cardiovascular disease: lessons from Tangier disease. (11227043)
2001
11
Accumulation of RhoA, RhoB, RhoG, and Rac1 in fibroblasts from Tangier disease subjects suggests a regulatory role of Rho family proteins in cholesterol efflux. (11162504)
2001
12
Accumulation of cardiolipin and lysocardiolipin in fibroblasts from Tangier disease subjects. (11445077)
2001
13
Tangier disease and ABCA1. (11111099)
2000
14
ABC1: the gene for Tangier disease and beyond. (10812922)
2000
15
Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency. (10787172)
2000
16
Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size. (10884295)
2000
17
Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. (10655069)
2000
18
Tangier disease as a test of the reverse cholesterol transport hypothesis. (11086021)
2000
19
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. (10431236)
1999
20
Digestive tract involvement in an infant and a child with Tangier disease. (9702662)
1998
21
Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I. (9610765)
1998
22
Decreased cholesterol efflux from fibroblasts of a patient without Tangier disease, but with markedly reduced high density lipoprotein cholesterol levels. (9506737)
1998
23
Generation of pre-beta 1-HDL and conversion into alpha-HDL. Evidence for disturbed HDL conversion in Tangier disease. (7583552)
1995
24
Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis. (8348751)
1993
25
Aortic features in Tangier disease and pathogenetic considerations--Part I. Fatty dots and streaks. (1380464)
1992
26
Tangier disease in a black patient: an unusual clinical presentation. (2164324)
1990
27
Apolipoprotein A-I: deficiency in Tangier disease. (3146917)
1988
28
Cardiac valvular involvement in Tangier disease. (3799433)
1987
29
Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes. (3109493)
1987
30
Tangier disease: a disorder of intracellular membrane traffic. (2994070)
1985
31
Tangier disease. A case with sensorimotor distal polyneuropathy and lipid accumulation in striated muscle and vasa nervorum. (2992211)
1985
32
The use of reversed-phase high-performance liquid chromatography to analyse the cholesterol ester profiles present in lipoproteins of patients exhibiting hyperalphalipoproteinaemia or hypoalphalipoproteinaemia (Tangier disease). (3934204)
1985
33
Tangier disease apolipoprotein A-I compared with normal plasma A-I using monoclonal antibodies. (2408675)
1985
34
Bile lipid composition and haemostatic variables in a case of high density lipoprotein deficiency (Tangier disease). (6421598)
1984
35
Massive omental reticuloendothelial cell lipid uptake in Tangier disease after splenectomy. (6614036)
1983
36
Peripheral neuropathy in Tangier disease. (6317140)
1983
37
Tangier disease with oral abnormalities. (6409822)
1983
38
Tangier disease: heterozygote detection and linkage analysis. (6951800)
1982
39
Tangier disease with normal serum cholesterol. (6960872)
1982
40
Morphology and cytometry of sural nerve in Tangier disease. (7183919)
1982
41
Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease). (6790903)
1981
42
The splanchnic autonomic outflow in amyloid neuropathy and Tangier disease. (7194438)
1981
43
Ocular manifestations of familial high-density lipoprotein deficiency (Tangier disease). (226043)
1979
44
Apoprotein A metabolism in Tangier disease. (213084)
1978
45
Abnormal concentration and anomalous distribution of apolipoprotein A-I in Tangier disease. (622047)
1978
46
Properties of the plasma very low and low density lipoproteins in Tangier disease. (201668)
1978
47
The storage lipids in Tangier disease. A physical chemical study. (193870)
1977
48
Tangier disease. (170484)
1975
49
Lipoproteins and lipolytic plasma enzymes in a case of tangier disease. (4368872)
1974
50
Neuropathy in Tangier disease. Alpha-Lipoprotein deficiency manifesting as familial recurrent neuropathy and intestinal lipid storage. (4165386)
1967

Variations for Tangier Disease

About this section

UniProtKB/Swiss-Prot genetic disease variations for Tangier Disease:

69 (show all 26)
id Symbol AA change Variation ID SNP ID
1ABCA1p.Arg587TrpVAR_009146rs2853574
2ABCA1p.Trp590SerVAR_009147rs137854496
3ABCA1p.Gln597ArgVAR_009148rs2853578
4ABCA1p.Asn935SerVAR_009150rs28937313
5ABCA1p.Ala937ValVAR_009151rs137854495
6ABCA1p.Asp1289AsnVAR_009152rs137854500
7ABCA1p.Cys1477ArgVAR_009153rs137854494
8ABCA1p.Ile1517ArgVAR_009154
9ABCA1p.Asn1800HisVAR_009155rs146292819
10ABCA1p.Ala255ThrVAR_012620rs758100110
11ABCA1p.Thr929IleVAR_012626
12ABCA1p.Ala1046AspVAR_012627rs141021096
13ABCA1p.Ser1506LeuVAR_012630rs137854497
14ABCA1p.Arg2081TrpVAR_012635rs137854501
15ABCA1p.Asn935HisVAR_037968rs28937314
16ABCA1p.Arg1680TrpVAR_037970rs137854498
17ABCA1p.Glu284LysVAR_062482
18ABCA1p.Tyr482CysVAR_062485
19ABCA1p.Trp590LeuVAR_062487rs137854496
20ABCA1p.Trp840ArgVAR_062491
21ABCA1p.Arg1068CysVAR_062493rs745593394
22ABCA1p.Leu1379PheVAR_062497
23ABCA1p.Val1704AspVAR_062501
24ABCA1p.Arg1851GlnVAR_062502
25ABCA1p.Arg1901SerVAR_062504
26ABCA1p.Gln2196HisVAR_062507rs564764153

Clinvar genetic disease variations for Tangier Disease:

5 (show all 24)
id Gene Variation Type Significance SNP ID Assembly Location
1APOA1NM_000039.2(APOA1): c.67C> T (p.Gln23Ter)SNVPathogenicrs387906570GRCh37Chr 11, 116707850: 116707850
2APOA1APOA1, 1-BP INSinsertionPathogenicChr na, -1: -1
3APOA1APOA1, IVS2, G-C, +1SNVPathogenicChr na, -1: -1
4ABCA1NM_005502.3(ABCA1): c.4429T> C (p.Cys1477Arg)SNVPathogenicrs137854494GRCh37Chr 9, 107568557: 107568557
5ABCA1NM_005502.3(ABCA1): c.3738+1G> CSNVPathogenicrs796051872GRCh37Chr 9, 107578423: 107578423
6ABCA1NM_005502.3(ABCA1): c.1790A> G (p.Gln597Arg)SNVPathogenicrs2853578GRCh37Chr 9, 107593308: 107593308
7ABCA1NM_005502.3(ABCA1): c.2080_2082delCTT (p.Leu694del)deletionPathogenicrs387906412GRCh37Chr 9, 107591230: 107591232
8ABCA1NM_005502.3(ABCA1): c.1824delG (p.Thr609Argfs)deletionPathogenicrs387906413GRCh37Chr 9, 107593274: 107593274
9ABCA1NM_005502.3(ABCA1): c.2804A> G (p.Asn935Ser)SNVPathogenicrs28937313GRCh37Chr 9, 107584801: 107584801
10ABCA1NM_005502.3(ABCA1): c.2810C> T (p.Ala937Val)SNVPathogenicrs137854495GRCh37Chr 9, 107584795: 107584795
11ABCA1NM_005502.3(ABCA1): c.1769G> C (p.Trp590Ser)SNVPathogenicrs137854496GRCh37Chr 9, 107593329: 107593329
12ABCA1NM_005502.3(ABCA1)indelPathogenicGRCh38Chr 9, 104831740: 104831753
13ABCA1NM_005502.3(ABCA1): c.3343_3344delTC (p.Ser1115Profs)deletionPathogenicrs387906414GRCh37Chr 9, 107581062: 107581063
14ABCA1NM_005502.3(ABCA1): c.6241C> T (p.Arg2081Trp)SNVPathogenicrs137854501GRCh37Chr 9, 107549221: 107549221
15ABCA1ABCA1, 1-BP DEL, 2665CdeletionPathogenicChr na, -1: -1
16ABCA1NM_005502.3(ABCA1): c.4517C> T (p.Ser1506Leu)SNVPathogenicrs137854497GRCh37Chr 9, 107566949: 107566949
17ABCA1NM_005502.3(ABCA1): c.2803A> C (p.Asn935His)SNVPathogenicrs28937314GRCh37Chr 9, 107584802: 107584802
18ABCA1NG_007981.1indelPathogenicChr na, -1: -1
19ABCA1NM_005502.3(ABCA1): c.3295G> T (p.Asp1099Tyr)SNVPathogenicrs28933692GRCh37Chr 9, 107581111: 107581111
20ABCA1NM_005502.3(ABCA1): c.6026T> C (p.Phe2009Ser)SNVPathogenicrs137854499GRCh37Chr 9, 107550750: 107550750
21ABCA1NM_005502.3(ABCA1): c.3865G> A (p.Asp1289Asn)SNVPathogenicrs137854500GRCh37Chr 9, 107576435: 107576435
22ABCA1NM_005502.3(ABCA1): c.3847_3850delCGCC (p.Pro1284Serfs)deletionPathogenicrs387906415GRCh37Chr 9, 107576450: 107576453
23ABCA1NM_005502.3(ABCA1): c.1719C> A (p.Tyr573Ter)SNVPathogenicrs137854502GRCh37Chr 9, 107593379: 107593379
24ABCA1NM_005502.3(ABCA1): c.656G> A (p.Arg219Lys)SNVprotectivers2230806GRCh37Chr 9, 107620867: 107620867

Expression for genes affiliated with Tangier Disease

About this section
Search GEO for disease gene expression data for Tangier Disease.

Pathways for genes affiliated with Tangier Disease

About this section

Pathways related to Tangier Disease according to GeneCards Suite gene sharing:

(show all 14)
idSuper pathwaysScoreTop Affiliating Genes
19.9ABCA1, ABCG1
29.9APOA1, APOB
39.8ABCA1, CETP
4
Show member pathways
9.6ABCA1, APOA1, APOB
5
Show member pathways
9.6ABCA1, APOA1, APOE
69.4ABCA1, ABCG1, APOA1, APOA2
79.3ALB, APOA1, APOE
89.3APOA1, APOA2, PLTP
9
Show member pathways
9.2APOA1, APOA2, APOB, APOE
10
Show member pathways
9.2APOA1, APOA2, APOB, APOE
11
Show member pathways
9.0ALB, APOA1, APOB, APOE
12
Show member pathways
7.6ABCA1, APOA1, APOA2, APOB, APOE, CETP
13
Show member pathways
6.3ABCA1, ABCG1, ALB, APOA1, APOA2, APOB
14
Show member pathways
6.3ABCA1, ABCG1, ALB, APOA1, APOA2, APOB

GO Terms for genes affiliated with Tangier Disease

About this section

Cellular components related to Tangier Disease according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1spherical high-density lipoprotein particleGO:003436610.6APOA1, APOA2
2intermediate-density lipoprotein particleGO:003436310.5APOB, APOE
3low-density lipoprotein particleGO:003436210.5APOB, APOE
4endocytic vesicle lumenGO:007168210.2APOA1, APOB, APOE
5endoplasmic reticulum lumenGO:000578810.0APOA1, APOA2, APOB
6chylomicronGO:00426279.9APOA1, APOA2, APOB, APOE
7very-low-density lipoprotein particleGO:00343619.9APOA1, APOA2, APOB, APOE
8early endosomeGO:00057699.6APOA1, APOA2, APOB, APOE
9high-density lipoprotein particleGO:00343649.2ABCA1, APOA1, APOA2, APOE, CETP, LCAT
10blood microparticleGO:00725629.0ALB, APOA1, APOA2, APOE
11Golgi apparatusGO:00057948.5ABCA1, ABCG1, ALB, APOB, APOE, NPC1
12extracellular spaceGO:00056157.4ALB, APOA1, APOA2, APOB, APOE, CETP
13extracellular exosomeGO:00700626.6ALB, APOA1, APOA2, APOB, APOE, CETP
14extracellular regionGO:00055766.5ALB, APOA1, APOA2, APOB, APOE, CETP

Biological processes related to Tangier Disease according to GeneCards Suite gene sharing:

(show all 42)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of cholesterol storageGO:001088710.6ABCA1, ABCG1
2protein oxidationGO:001815810.6APOA1, APOA2
3regulation of intestinal cholesterol absorptionGO:003030010.6APOA1, APOA2
4negative regulation of lipase activityGO:006019210.6APOA1, APOA2
5negative regulation of very-low-density lipoprotein particle remodelingGO:001090310.6APOA1, APOA2
6intracellular cholesterol transportGO:003236710.6ABCA1, ABCG1
7peptidyl-methionine modificationGO:001820610.5APOA1, APOA2
8negative regulation of cytokine secretion involved in immune responseGO:000274010.5APOA1, APOA2
9neuron projection regenerationGO:003110210.5APOA1, APOE
10lipoprotein catabolic processGO:004215910.4APOB, APOE
11phosphatidylcholine metabolic processGO:004647010.3CETP, LCAT
12triglyceride homeostasisGO:007032810.3APOA1, CETP
13artery morphogenesisGO:004884410.3APOB, APOE
14regulation of Cdc42 protein signal transductionGO:003248910.2ABCA1, APOA1, APOE
15positive regulation of cholesterol esterificationGO:001087310.2APOA1, APOA2, APOE
16high-density lipoprotein particle clearanceGO:003438410.2APOA1, APOA2, APOE
17phosphatidylcholine biosynthetic processGO:000665610.1APOA1, APOA2, LCAT
18phospholipid transportGO:001591410.1ABCA1, APOA1, CETP
19negative regulation of macrophage derived foam cell differentiationGO:001074510.0ABCA1, ABCG1, CETP
20very-low-density lipoprotein particle remodelingGO:003437210.0APOE, CETP, LCAT
21high-density lipoprotein particle assemblyGO:00343809.9ABCA1, APOA1, APOA2, APOE
22response to nutrientGO:00075849.9ABCA1, ALB, APOA1
23triglyceride catabolic processGO:00194339.8APOA1, APOB, APOE
24phospholipid homeostasisGO:00550919.8ABCA1, ABCG1, APOA1, CETP
25triglyceride metabolic processGO:00066419.8APOA2, APOE, CETP
26phospholipid effluxGO:00337009.7ABCA1, ABCG1, APOA1, APOA2, APOE
27positive regulation of cholesterol effluxGO:00108759.6ABCA1, ABCG1, APOE, PLTP
28response to organic substanceGO:00100339.6ABCG1, ALB, APOB
29retinoid metabolic processGO:00015239.4APOA1, APOA2, APOB, APOE
30low-density lipoprotein particle remodelingGO:00343749.3ABCG1, APOA2, APOB, APOE, CETP
31lipoprotein biosynthetic processGO:00421589.3ABCA1, APOA1, APOA2, APOB, APOE, LCAT
32lipid transportGO:00068699.2APOA2, CETP, LPA, PLTP
33response to drugGO:00424939.1ABCA1, APOA1, APOA2, NPC1
34lipid metabolic processGO:00066298.9APOB, APOE, LPA, PLTP
35reverse cholesterol transportGO:00436918.8ABCA1, ABCG1, APOA1, APOA2, APOE, CETP
36cholesterol effluxGO:00333448.8ABCA1, ABCG1, APOA1, APOA2, APOB, APOE
37receptor-mediated endocytosisGO:00068988.7ALB, APOA1, APOB, APOE, CETP
38high-density lipoprotein particle remodelingGO:00343758.5ABCG1, APOA1, APOA2, APOE, CETP, LCAT
39cholesterol transportGO:00303018.3ABCA1, ABCG1, APOA1, APOA2, APOB, CETP
40cholesterol homeostasisGO:00426327.7ABCA1, ABCG1, APOA1, APOA2, APOB, APOE
41cholesterol metabolic processGO:00082037.7ABCA1, ABCG1, APOA1, APOA2, APOB, APOE
42lipoprotein metabolic processGO:00421577.4ABCA1, ABCG1, ALB, APOA1, APOA2, APOB

Molecular functions related to Tangier Disease according to GeneCards Suite gene sharing:

(show all 19)
idNameGO IDScoreTop Affiliating Genes
1high-density lipoprotein particle receptor bindingGO:007065310.5APOA1, APOA2
2lipase inhibitor activityGO:005510210.5APOA1, APOA2
3apolipoprotein A-I bindingGO:003418610.5ABCA1, LCAT
4apolipoprotein receptor bindingGO:003419010.5APOA1, APOA2
5high-density lipoprotein particle bindingGO:000803510.4APOA1, APOA2
6lipoprotein particle bindingGO:007181310.3APOA1, APOE
7apolipoprotein bindingGO:003418510.3ABCA1, LPA
8phosphatidylcholine-sterol O-acyltransferase activator activityGO:006022810.1APOA1, APOA2, APOE
9antioxidant activityGO:001620910.1ALB, APOE
10beta-amyloid bindingGO:00015409.9APOA1, APOE
11phosphatidylcholine bindingGO:00312109.9APOA1, APOA2, CETP
12low-density lipoprotein particle receptor bindingGO:00507509.8APOB, APOE
13phospholipid transporter activityGO:00055489.7ABCA1, ABCG1, APOA1, CETP
14lipid transporter activityGO:00053199.6APOA1, APOA2, APOE, CETP
15heparin bindingGO:00082019.5APOB, APOE, LPA
16phospholipid bindingGO:00055438.7ABCA1, ABCG1, APOA1, APOA2, APOB, APOE
17cholesterol transporter activityGO:00171278.7ABCA1, ABCG1, APOA1, APOA2, APOB, APOE
18cholesterol bindingGO:00154858.5ABCA1, ABCG1, APOA1, APOA2, APOE, CETP
19lipid bindingGO:00082897.8APOA1, APOA2, APOB, APOE, CETP, PLTP

Sources for Tangier Disease

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet